Advanced Search

Publications > Journals > Journal of Clinical and Translational Pathology > Special Issue

Recent developments in genitourinary pathology

Submit your manuscript

  • Special Issue Information
  • Articles
Topic Editors

Neoplastic diseases of the genitourinary (GU) system are the most common among all human systems in the United States, accounting for approximately 40% of all male cancers. Prostate, bladder, and kidney cancers rank first, fourth, and sixth, respectively, in terms of cancer incidence. Additionally, testicular cancer is the most common malignant disease in young men in the age group of 15-44 years. It is essential for pathologists and researchers to be updated with new developments in the diagnosis and research of GU cancers. For this special issue, we invite front-line pathologists and researchers to submit high-quality scientific manuscripts regarding GU cancers. Potential topics include, but are not limited to:

1. Cohort- or case- studies to characterize clinicopathologic features of GU cancers
2. New developments in diagnostic criteria
3. Use of biomarkers in diagnosis, prognosis, and prediction of therapeutic response
4. Laboratory investigations to implore the molecular mechanism underlying the development and progression

Priority will be given to articles that have significant impacts on the diagnosis and treatment of GU cancers with a high standard of peer review. All publications will be open access to all readers. All accepted papers will be highlighted in a special issue for GU pathology on our website.

Publication date: An article will be published online as soon as it is accepted.

Guest Editor

Charles Guo

Read More

Dr. Charles Guo is Professor of Pathology and Chief of Genitourinary (GU) Pathology Section at the University of Texas MD Anderson Cancer Center.

Guest Editor

Guoping Cai

Read More

Dr. Cai is a Professor of Pathology and the Associate Director of Cytopathology at the Department of Pathology, Yale University School of Medicine.

Important Dates

Submission open date: June 30, 2022

Submission deadline: November 30, 2022